OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Prognostic significance of 68Ga-Pentixafor PET/CT in multiple myeloma recurrence: a comparison to 18F-FDG PET/CT and laboratory results
Serkan Kuyumcu, Emine Göknur Işık, Tarık Onur Tiryaki, et al.
Annals of Nuclear Medicine (2021) Vol. 35, Iss. 10, pp. 1147-1156
Closed Access | Times Cited: 28
Serkan Kuyumcu, Emine Göknur Işık, Tarık Onur Tiryaki, et al.
Annals of Nuclear Medicine (2021) Vol. 35, Iss. 10, pp. 1147-1156
Closed Access | Times Cited: 28
Showing 1-25 of 28 citing articles:
Diagnostic Innovations: Advances in imaging techniques for diagnosis and follow-up of multiple myeloma
Martina Talarico, Simona Barbato, A. Cattabriga, et al.
Journal of bone oncology (2025) Vol. 51, pp. 100669-100669
Open Access | Times Cited: 1
Martina Talarico, Simona Barbato, A. Cattabriga, et al.
Journal of bone oncology (2025) Vol. 51, pp. 100669-100669
Open Access | Times Cited: 1
Advances in PET Imaging of the CXCR4 Receptor: [68Ga]Ga-PentixaFor
Liza Lindenberg, Mark A. Ahlman, Frank I. Lin, et al.
Seminars in Nuclear Medicine (2023) Vol. 54, Iss. 1, pp. 163-170
Closed Access | Times Cited: 18
Liza Lindenberg, Mark A. Ahlman, Frank I. Lin, et al.
Seminars in Nuclear Medicine (2023) Vol. 54, Iss. 1, pp. 163-170
Closed Access | Times Cited: 18
Minimal Residual Disease in Multiple Myeloma: Past, Present, and Future
Alejandro Medina, María Eugenia Sarasquete, Cristina Jiménez, et al.
Cancers (2023) Vol. 15, Iss. 14, pp. 3687-3687
Open Access | Times Cited: 15
Alejandro Medina, María Eugenia Sarasquete, Cristina Jiménez, et al.
Cancers (2023) Vol. 15, Iss. 14, pp. 3687-3687
Open Access | Times Cited: 15
In Vivo Targeting of CXCR4—New Horizons
Margret Schottelius, Ken Herrmann, Constantin Lapa
Cancers (2021) Vol. 13, Iss. 23, pp. 5920-5920
Open Access | Times Cited: 32
Margret Schottelius, Ken Herrmann, Constantin Lapa
Cancers (2021) Vol. 13, Iss. 23, pp. 5920-5920
Open Access | Times Cited: 32
[68Ga]Pentixafor PET/CT for staging and prognostic assessment of newly diagnosed multiple myeloma: comparison to [18F]FDG PET/CT
Zhenying Chen, Apeng Yang, Ai−Hong Chen, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2024) Vol. 51, Iss. 7, pp. 1926-1936
Closed Access | Times Cited: 4
Zhenying Chen, Apeng Yang, Ai−Hong Chen, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2024) Vol. 51, Iss. 7, pp. 1926-1936
Closed Access | Times Cited: 4
Ga-68 Pentixafor PET/CT in multiple myeloma and its correlation with clinical parameters: institutional pilot study
Dinesh Kumar Gauthaman, Indirani Muthukrishnan, Kunjan Acharya, et al.
Annals of Nuclear Medicine (2025)
Open Access
Dinesh Kumar Gauthaman, Indirani Muthukrishnan, Kunjan Acharya, et al.
Annals of Nuclear Medicine (2025)
Open Access
68Ga-Pentixafor PET/CT–Based Response Evaluation and its Prognostic Value in Multiple Myeloma: Comparison With IMWG and 18F-FDG–Based Response
Harneet Kaur, Suraj Kumar, Ankit Watts, et al.
Clinical Nuclear Medicine (2025)
Closed Access
Harneet Kaur, Suraj Kumar, Ankit Watts, et al.
Clinical Nuclear Medicine (2025)
Closed Access
Head-to-Head Comparison of 68Ga-PentixaFor PET/CT and FDG PET/CT for Detecting Hematologic and Solid Cancers: A Systematic Review and Meta-Analysis
Weichen Wang, Mingxing Huang, Rong Tian, et al.
American Journal of Roentgenology (2025)
Closed Access
Weichen Wang, Mingxing Huang, Rong Tian, et al.
American Journal of Roentgenology (2025)
Closed Access
New Developments in Myeloma Treatment and Response Assessment
Françoise Kraeber‐Bodéré, Bastien Jamet, Davide Bezzi, et al.
Journal of Nuclear Medicine (2023) Vol. 64, Iss. 9, pp. 1331-1343
Open Access | Times Cited: 9
Françoise Kraeber‐Bodéré, Bastien Jamet, Davide Bezzi, et al.
Journal of Nuclear Medicine (2023) Vol. 64, Iss. 9, pp. 1331-1343
Open Access | Times Cited: 9
The cutting edge: Promising oncology radiotracers in clinical development
Jorge D. Oldan, Martin G. Pomper, Rudolf A. Werner, et al.
Diagnostic and Interventional Imaging (2024) Vol. 105, Iss. 10, pp. 400-406
Closed Access | Times Cited: 3
Jorge D. Oldan, Martin G. Pomper, Rudolf A. Werner, et al.
Diagnostic and Interventional Imaging (2024) Vol. 105, Iss. 10, pp. 400-406
Closed Access | Times Cited: 3
Nuclear Medicine Application of Pentixafor/Pentixather Targeting CXCR4 for Imaging and Therapy in Related Disease
Zhenying Chen, Qianqian Xue, Shaobo Yao
Mini-Reviews in Medicinal Chemistry (2022) Vol. 23, Iss. 7, pp. 787-803
Closed Access | Times Cited: 13
Zhenying Chen, Qianqian Xue, Shaobo Yao
Mini-Reviews in Medicinal Chemistry (2022) Vol. 23, Iss. 7, pp. 787-803
Closed Access | Times Cited: 13
The Clinical Role of CXCR4-Targeted PET on Lymphoproliferative Disorders: A Systematic Review
Maryam Zamanian, Domenico Albano, Giorgio Treglia, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 10, pp. 2945-2945
Open Access | Times Cited: 2
Maryam Zamanian, Domenico Albano, Giorgio Treglia, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 10, pp. 2945-2945
Open Access | Times Cited: 2
Clinical Value of FDG-PET/CT in Multiple Myeloma: An Update
Davide Bezzi, Valentina Ambrosini, Cristina Nanni
Seminars in Nuclear Medicine (2022) Vol. 53, Iss. 3, pp. 352-370
Closed Access | Times Cited: 11
Davide Bezzi, Valentina Ambrosini, Cristina Nanni
Seminars in Nuclear Medicine (2022) Vol. 53, Iss. 3, pp. 352-370
Closed Access | Times Cited: 11
The Apparent Diffusion Coefficient of Diffusion-Weighted Whole-Body Magnetic Resonance Imaging Affects the Survival of Multiple Myeloma Independently
Bei Zhang, Bingyang Bian, Yanjiao Zhang, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 9
Bei Zhang, Bingyang Bian, Yanjiao Zhang, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 9
The role of 68Ga-Pentixafor PET in multiple myeloma
Min Wang, Jiayu Zhang, Liyi Liu, et al.
Clinical and Translational Imaging (2023) Vol. 11, Iss. 5, pp. 453-463
Closed Access | Times Cited: 5
Min Wang, Jiayu Zhang, Liyi Liu, et al.
Clinical and Translational Imaging (2023) Vol. 11, Iss. 5, pp. 453-463
Closed Access | Times Cited: 5
New PET Tracers for Symptomatic Myeloma
Sambit Sagar, Dikhra Khan, Kanankulam Velliangiri Sivasankar, et al.
PET Clinics (2024) Vol. 19, Iss. 4, pp. 515-524
Closed Access | Times Cited: 1
Sambit Sagar, Dikhra Khan, Kanankulam Velliangiri Sivasankar, et al.
PET Clinics (2024) Vol. 19, Iss. 4, pp. 515-524
Closed Access | Times Cited: 1
Selective PET imaging of CXCR4 using the Al18F-labeled antagonist LY2510924
M. SPAHN, Tom Van Loy, Sofie Celen, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2024)
Open Access | Times Cited: 1
M. SPAHN, Tom Van Loy, Sofie Celen, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2024)
Open Access | Times Cited: 1
Molecular Imaging in Multiple Myeloma—Novel PET Radiotracers Improve Patient Management and Guide Therapy
Johannes von Hinten, Malte Kircher, Alexander Dierks, et al.
Frontiers in Nuclear Medicine (2022) Vol. 2
Open Access | Times Cited: 4
Johannes von Hinten, Malte Kircher, Alexander Dierks, et al.
Frontiers in Nuclear Medicine (2022) Vol. 2
Open Access | Times Cited: 4
[68Ga]-Pentixafor PET/CT imaging of lymphoproliferative malignancies
Serkan Kuyumcu, Murat Yılmaz Kıran, Evşen Apaydın Arıkan, et al.
Clinical and Translational Imaging (2021) Vol. 9, Iss. 6, pp. 641-648
Closed Access | Times Cited: 5
Serkan Kuyumcu, Murat Yılmaz Kıran, Evşen Apaydın Arıkan, et al.
Clinical and Translational Imaging (2021) Vol. 9, Iss. 6, pp. 641-648
Closed Access | Times Cited: 5
Metabolic Volume Measurements in Multiple Myeloma
Maria Emília Seren Takahashi, Irene Lorand‐Metze, Cármino Antônio De Souza, et al.
Metabolites (2021) Vol. 11, Iss. 12, pp. 875-875
Open Access | Times Cited: 4
Maria Emília Seren Takahashi, Irene Lorand‐Metze, Cármino Antônio De Souza, et al.
Metabolites (2021) Vol. 11, Iss. 12, pp. 875-875
Open Access | Times Cited: 4
Functional Imaging in the Evaluation of Treatment Response in Multiple Myeloma: The Role of PET-CT and MRI
Adele Santoni, Martina Simoncelli, Marta Franceschini, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 11, pp. 1885-1885
Open Access | Times Cited: 3
Adele Santoni, Martina Simoncelli, Marta Franceschini, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 11, pp. 1885-1885
Open Access | Times Cited: 3
The assessment of left ventricular volume and function in gated small animal 18F-FDG PET/CT imaging: a comparative study of three commercially available software tools
Mathias J. Zacherl, Agus Simenhandra, Magdalena Lindner, et al.
EJNMMI Research (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 1
Mathias J. Zacherl, Agus Simenhandra, Magdalena Lindner, et al.
EJNMMI Research (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 1
Tata Memorial Centre Evidence Based Use of Nuclear medicine diagnostic and treatment modalities in cancer
Ameya Puranik, Sayak Choudhury, Suchismita Ghosh, et al.
Indian Journal of Cancer (2024) Vol. 61, Iss. Suppl 1, pp. S1-S28
Open Access
Ameya Puranik, Sayak Choudhury, Suchismita Ghosh, et al.
Indian Journal of Cancer (2024) Vol. 61, Iss. Suppl 1, pp. S1-S28
Open Access
Theranostik
Konrad Mohnike, Frank Rösch, Ken Herrmann
Springer eBooks (2024), pp. 639-653
Closed Access
Konrad Mohnike, Frank Rösch, Ken Herrmann
Springer eBooks (2024), pp. 639-653
Closed Access
CXCR4-Targeted PET Imaging in Hematologic Malignancies
Mohammadreza Chavoshi, Seyed Ali Mirshahvalad, Andrés Kohan, et al.
Clinical Nuclear Medicine (2024)
Closed Access
Mohammadreza Chavoshi, Seyed Ali Mirshahvalad, Andrés Kohan, et al.
Clinical Nuclear Medicine (2024)
Closed Access
